Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption

CONTEXT: The effect of sotagliflozin (a dual sodium–glucose cotransporter [SGLT] 2 and SGLT1 inhibitor) on intestinal glucose absorption has not been investigated in humans. OBJECTIVE: To measure rate of appearance of oral glucose (R(a)O) using a dual glucose tracer method following standardized mix...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, David R, Zambrowicz, Brian, Morrow, Linda, Beysen, Carine, Hompesch, Marcus, Turner, Scott, Hellerstein, Marc, Banks, Phillip, Strumph, Paul, Lapuerta, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067537/
https://www.ncbi.nlm.nih.gov/pubmed/31837264
http://dx.doi.org/10.1210/clinem/dgz258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067537/
https://www.ncbi.nlm.nih.gov/pubmed/31837264
http://dx.doi.org/10.1210/clinem/dgz258

Ejemplares similares